Financhill
Buy
73

NKTR Quote, Financials, Valuation and Earnings

Last price:
$56.00
Seasonality move :
1.26%
Day range:
$47.05 - $56.76
52-week range:
$6.48 - $66.92
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
57.74x
P/B ratio:
11.39x
Volume:
8.7M
Avg. volume:
961.3K
1-year change:
433.34%
Market cap:
$968.8M
Revenue:
$98.4M
EPS (TTM):
-$4.56

Nektar Therapeutics SEC Filings

Company Filed Form Type Description
NKTR
Nektar Therapeutics
05/10/2024 10-Q 10-Q filing on 05/10/2024 View Form
NKTR
Nektar Therapeutics
11/08/2023 10-Q 10-Q filing on 11/08/2023 View Form
NKTR
Nektar Therapeutics
08/09/2023 10-Q 10-Q filing on 08/09/2023 View Form
NKTR
Nektar Therapeutics
05/10/2023 10-Q 10-Q filing on 05/10/2023 View Form
NKTR
Nektar Therapeutics
11/04/2022 10-Q 10-Q filing on 11/04/2022 View Form
NKTR
Nektar Therapeutics
08/05/2022 10-Q 10-Q filing on 08/05/2022 View Form
NKTR
Nektar Therapeutics
05/06/2022 10-Q 10-Q filing on 05/06/2022 View Form
NKTR
Nektar Therapeutics
11/05/2021 10-Q 10-Q filing on 11/05/2021 View Form
NKTR
Nektar Therapeutics
08/06/2021 10-Q 10-Q filing on 08/06/2021 View Form
NKTR
Nektar Therapeutics
05/07/2021 10-Q 10-Q filing on 05/07/2021 View Form
NKTR
Nektar Therapeutics
11/06/2020 10-Q 10-Q filing on 11/06/2020 View Form
NKTR
Nektar Therapeutics
08/07/2020 10-Q 10-Q filing on 08/07/2020 View Form
NKTR
Nektar Therapeutics
05/08/2020 10-Q 10-Q filing on 05/08/2020 View Form
NKTR
Nektar Therapeutics
02/28/2020 10-K 10-K filing on 02/28/2020 View Form
NKTR
Nektar Therapeutics
11/07/2019 10-Q 10-Q filing on 11/07/2019 View Form
NKTR
Nektar Therapeutics
08/09/2019 10-Q 10-Q filing on 08/09/2019 View Form
NKTR
Nektar Therapeutics
05/09/2019 10-Q 10-Q filing on 05/09/2019 View Form
NKTR
Nektar Therapeutics
03/01/2019 10-K 10-K filing on 03/01/2019 View Form
NKTR
Nektar Therapeutics
11/08/2018 10-Q 10-Q filing on 11/08/2018 View Form
NKTR
Nektar Therapeutics
08/09/2018 10-Q 10-Q filing on 08/09/2018 View Form
NKTR
Nektar Therapeutics
05/10/2018 10-Q 10-Q filing on 05/10/2018 View Form
NKTR
Nektar Therapeutics
03/01/2018 10-K 10-K filing on 03/01/2018 View Form
NKTR
Nektar Therapeutics
11/08/2017 10-Q 10-Q filing on 11/08/2017 View Form
NKTR
Nektar Therapeutics
08/09/2017 10-Q 10-Q filing on 08/09/2017 View Form
NKTR
Nektar Therapeutics
05/10/2017 10-Q 10-Q filing on 05/10/2017 View Form
NKTR
Nektar Therapeutics
03/01/2017 10-K 10-K filing on 03/01/2017 View Form
NKTR
Nektar Therapeutics
11/04/2016 10-Q 10-Q filing on 11/04/2016 View Form
NKTR
Nektar Therapeutics
08/04/2016 10-Q 10-Q filing on 08/04/2016 View Form
NKTR
Nektar Therapeutics
05/04/2016 10-Q 10-Q filing on 05/04/2016 View Form
NKTR
Nektar Therapeutics
02/29/2016 10-K 10-K filing on 02/29/2016 View Form

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Will UnitedHealth Stock Recover?
Will UnitedHealth Stock Recover?

Shares of embattled health insurance giant UnitedHealth (NYSE:UNH) plummeted by…

Is Lumentum The Best Laser Stock to Buy?
Is Lumentum The Best Laser Stock to Buy?

Though certainly less well-known than the huge tech businesses that…

Is Planet Fitness Stock Undervalued?
Is Planet Fitness Stock Undervalued?

Planet Fitness (NYSE:PLNT) has had a difficult 12 months, retreating…

Stock Ideas

Buy
55
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
58
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Sell
48
Is GOOG Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 29x

Alerts

Buy
73
NKTR alert for Feb 11

Nektar Therapeutics [NKTR] is up 13.71% over the past day.

Buy
53
ICHR alert for Feb 11

Ichor Holdings Ltd. [ICHR] is up 0.2% over the past day.

Sell
26
MEDP alert for Feb 11

Medpace Holdings, Inc. [MEDP] is down 3.85% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock